Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: Midterm outcomes in a single-center experience

Articolo
Data di Pubblicazione:
2014
Abstract:
Objective: The study objective was to report the midterm outcomes of MitraClip implantation in inoperable or high-risk surgical candidates with degenerative mitral regurgitation. Methods: From October 2008, data of all high-risk or elderly patients with severe degenerative mitral regurgitation who underwent MitraClip implantation were prospectively collected. Results: Forty-eight high-risk consecutive patients with severe degenerative mitral regurgitation underwent MitraClip implantation (mean age, 78.5 +/- 10.8 years; 56.6% of the patients were aged >= 80 years). Mean Society of Thoracic Surgeons score was 12% +/- 10%, and 71% were in New York Heart Association class III or IV. Mean left ventricular ejection fraction was 57% +/- 11%. The device was successfully implanted in 47 of 48 patients (98%). In-hospital mortality was 2%. The median intensive care unit stay was 22 hours; patients were discharged from the hospital in an average of 4.5 +/- 2.4 days. Predischarge echocardiography showed a mitral regurgitation reduction to grade 2+ or less in 43 of 47 patients (91.5%). Actuarial survival was 89% +/- 5.2% and 70.2% +/- 9% at 1 and 2 years, respectively (82% +/- 9% in patients aged <80 years and 95% +/- 4.4% in patients aged >= 80 years at 1 year; P = .9). Freedom from mitral regurgitation 3+ or greater was 80% +/- 7% at 1 year and 76.6% +/- 7% at 2 years. At 1 year, 93% of survivors were in New York Heart Association class I or II (100% of patients aged <80 years and 88% of patients aged >= 80 years; P = .4). Significant quality of life improvements were documented. A significant improvement in 6-minute walk test performance was observed. Conclusions: MitraClip therapy is a valuable alternative to surgery in high-risk and elderly patients with degenerative mitral regurgitation. Clinical benefits also are obtained in octogenarians. OI Denti, Paolo/0000-0002-3075-0203
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Taramasso, M; Maisano, F; Denti, P; Latib, A; La Canna, G; Colombo, A; Alfieri, Ottavio
Autori di Ateneo:
MAISANO FRANCESCO
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/9593
Pubblicato in:
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0